Kathy S. Albain, MD, on Racial Disparities in Breast Cancer Outcomes From TAILORx Trial

Posted: Friday, December 14, 2018

Kathy S. Albain, MD, of Loyola University Stritch School of Medicine, discusses study findings on race, ethnicity, and patient outcomes in hormone receptor–positive, HER2-negative, node-negative breast cancer.